1. Home
  2. JBLU vs EVO Comparison

JBLU vs EVO Comparison

Compare JBLU & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo JetBlue Airways Corporation

JBLU

JetBlue Airways Corporation

N/A

Current Price

$3.16

Market Cap

1.1B

ML Signal

N/A

Logo Evotec SE

EVO

Evotec SE

N/A

Current Price

$1.56

Market Cap

568.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
JBLU
EVO
Founded
1998
1993
Country
United States
Germany
Employees
N/A
N/A
Industry
Air Freight/Delivery Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
568.6M
IPO Year
2002
2007

Fundamental Metrics

Financial Performance
Metric
JBLU
EVO
Price
$3.16
$1.56
Analyst Decision
Hold
Buy
Analyst Count
17
3
Target Price
$4.10
★ $4.21
AVG Volume (30 Days)
★ 31.0M
83.3K
Earning Date
10-26-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 27.83
N/A
EPS
N/A
★ N/A
Revenue
★ $9,062,000,000.00
N/A
Revenue This Year
$16.21
N/A
Revenue Next Year
$9.13
$20.47
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$2.16
$1.33
52 Week High
$6.62
$3.87

Technical Indicators

Market Signals
Indicator
JBLU
EVO
Relative Strength Index (RSI) 48.04 51.01
Support Level $2.16 $1.50
Resistance Level $6.31 $1.97
Average True Range (ATR) 0.27 0.04
MACD 0.09 0.02
Stochastic Oscillator 94.44 82.61

Price Performance

Historical Comparison
JBLU
EVO

About JBLU JetBlue Airways Corporation

JetBlue Airways Corp is a low-cost airline that offers high-quality service, including assigned seating and in-flight entertainment. It served approximately 100 destinations in the United States, the Caribbean and Latin America, Canada, and England. The company currently operates Airbus A321, Airbus A320, Airbus A321neo, and Embraer E190 aircraft types. The company has one operating segment, Air Transportation Services, which provides services in the United States, the Caribbean, Latin America, Canada, and Europe. The majority of revenue is generated from the Domestic & Canada segment.

About EVO Evotec SE

Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.

Share on Social Networks: